A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis

SIMPLE SUMMARY: This multicenter cohort study is the first to compare the clinical outcomes between the Atezolizumab-plus-bevacizumab (Ate/Bev) and transarterial-chemoembolization-plus-radiotherapy (TACE + RT) therapies in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PV...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soon Kyu, Kwon, Jung Hyun, Lee, Sung Won, Lee, Hae Lim, Kim, Hee Yeon, Kim, Chang Wook, Song, Do Seon, Chang, U Im, Yang, Jin Mo, Nam, Soon Woo, Kim, Seok-Hwan, Song, Myeong Jun, Kim, Ji Hoon, Lee, Ahlim, Yang, Hyun, Bae, Si Hyun, Han, Ji Won, Nam, Heechul, Sung, Pil Soo, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew, Shim, Dong Jae, Kim, Doyoung, Kim, Myungsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486735/
https://www.ncbi.nlm.nih.gov/pubmed/37686699
http://dx.doi.org/10.3390/cancers15174423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486735/
https://www.ncbi.nlm.nih.gov/pubmed/37686699
http://dx.doi.org/10.3390/cancers15174423

Ejemplares similares